EGFR and cancer: In this review, we summarize the protumoral activity of PGE2 inflammatory pathways, mainly focusing on the interplay with the epidermal growth factor receptor (EGFR), and we show the recent advancement in the pharmacological modulation of these signaling pathways in cancer management.